Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,047,859
-$340,176 QoQ
Shares Held
85,044
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#952
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN STRUM & TOWNE INC. holds $44,052,208 across 8 Drug Manufacturers - General names. PFE ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
44,632 | $11,335,189 | |
| 2 | AMGN |
Amgen Inc
|
31,250 | $11,316,250 | |
| 3 | ABBV |
AbbVie Inc.
|
37,773 | $9,505,197 | |
| 4 | LLY |
ELI LILLY & Co
|
5,679 | $6,811,563 | |
| 5 | PFE |
Pfizer Inc
This page
|
85,044 | $2,047,859 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,293 | $1,708,150 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,392 | $944,507 | |
| 8 | NVS |
Novartis AG
|
2,447 | $383,493 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,047,859 | 85,044 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,388,035 | 85,044 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,127,555 | 85,444 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,158,003 | 84,694 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $2,073,344 | 85,534 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $2,168,698 | 85,584 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,848,716 | 69,684 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,910,879 | 66,029 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,830,003 | 65,404 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,814,961 | 65,404 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,862,252 | 64,684 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,040,253 | 61,509 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,256,150 | 61,509 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,495,858 | 61,173 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,156,742 | 61,607 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $2,711,238 | 61,957 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,252,337 | 62,032 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,213,985 | 62,082 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,662,458 | 62,023 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $2,680,512 | 62,323 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,452,316 | 62,623 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $2,251,078 | 62,133 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $2,287,115 | 62,133 | Shares | Defined | 2021-02-03 | |
| 2020-09-30 | $2,097,880 | 57,163 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,887,053 | 57,708 | Shares | Defined | 2020-07-14 | |
| 2020-03-31 | $1,892,986 | 57,996 | Shares | Defined | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||